[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.3.44. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 13, 1991

Neurobehavioral Effects of Phenytoin Prophylaxis of Posttraumatic Seizures

Author Affiliations

From the Departments of Rehabilitation Medicine (Dr Dikmen and Mss Miller and Machamer), Neurological Surgery (Drs Dikmen, Temkin, and Winn) and Biostatistics (Dr Temkin), University of Washington, Seattle.

From the Departments of Rehabilitation Medicine (Dr Dikmen and Mss Miller and Machamer), Neurological Surgery (Drs Dikmen, Temkin, and Winn) and Biostatistics (Dr Temkin), University of Washington, Seattle.

JAMA. 1991;265(10):1271-1277. doi:10.1001/jama.1991.03460100073027
Abstract

In order to determine potential negative neurobehavioral effects of phenytoin given to prevent the development of posttraumatic seizures, 244 subjects were randomized to phenytoin or placebo. They received neurobehavioral assessments at 1 and 12 months postinjury while receiving their assigned drug and at 24 months while receiving no drugs. In the severely injured, phenytoin significantly impaired performance at 1 month. No significant differences were found as a function of phenytoin in the moderately injured patients at 1 month or in either severity group at 1 year. Patients who stopped receiving phenytoin according to protocol between 1 and 2 years improved more than corresponding placebo cases on several measures. We conclude that phenytoin has negative cognitive effects. This, combined with lack of evidence for its effectiveness in preventing posttraumatic seizures beyond the first week, raises questions regarding its use for long-term prophylaxis. Our findings do not negate phenytoin's proven efficacy in controlling established seizures nor do they indicate that its cognitive effects are worse than other anticonvulsant drugs.

(JAMA. 1991;265:1271-1277)

×